The efficacy of silver dressings and antibiotics on MRSA and MSSA isolated from burn patients

Wound Repair and Regeneration

Volumn 19, Issue 6, 2011, Pages 767-774

  Percival, Steven L ^a,b   Thomas, John G ^a   Slone, Will ^a   Linton, Sara ^a   Corum, Linda ^a   Okel, Tyler ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Advanced Medical Solutions Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BIOMATERIAL; CLINDAMYCIN; SILVER ALGINATE; SILVER CARBOXYMETHYL CELLULOSE; SILVER DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; BIOFILM; BURN; BURN PATIENT; CONTROLLED STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TEST; NONHUMAN; PH; PRIORITY JOURNAL; SILVER ALGINATE WOUND DRESSING; SILVER CARBOXYMETHYL CELLULOSE WOUND DRESSING; SOUTH AFRICA; WOUND DRESSING;

AMPICILLIN; ANTI-BACTERIAL AGENTS; BANDAGES; BIOFILMS; BURNS; CLINDAMYCIN; CULTURE MEDIA; HUMANS; HYDROGEN-ION CONCENTRATION; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; SILVER; SILVER COMPOUNDS; STAPHYLOCOCCUS AUREUS;

EID: 80155208366     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2011.00739.x     Document Type: Article

References (40)

1. Weinrick B, Dunman PM, McAleese F, Murphy E, Projan SJ, Fang Y, Novick RP,. Effect of mild acid on gene expression in Staphylococcus aureus. J Bacteriol 2004; 186: 8407-8423. (Pubitemid 39603232)
2. Cotter PD, Hill C,. Surviving the acid test: response of gram positive bacteria to low pH. Microbiol Mol Biol Rev 2003; 67: 429-453. (Pubitemid 37122528)
3. Agnihotri N, Gupta V, Joshi RM,. Aerobic bacterial isolates from burn wound infections and their antibiograms: a five-year study. Burns 2004; 30: 241-243. (Pubitemid 38479902)
4. Oncul O, Ulkur E, Acar A, Turhan V, Yeniz E, Karacaer Z, Yildiz F,. Prospective analysis of nosocomial infections in a burn care unit, Turkey. Indian J Med Res 2009; 130: 758-764.
5. Black CE, Costerton JW,. Current concepts regarding the effect of wound microbial ecology and biofilms on wound healing. Surg Clin North Am 2010; 90: 1147-1160.
6. Kennedy P, Brammah S, Wills E,. Burns, biofilm and a new appraisal of burn wound sepsis. Burns 2010; 36: 49-56.
7. Percival SL, Bowler PG, Dolman J,. Antimicrobial activity of silver-containing dressings on wound microorganisms using an in vitro biofilm model. Int Wound J 2007; 4: 186-191.
8. Wolcott RD, Rhoads DD, Bennett ME, Wolcott BM, Gogokhia L, Costerton JW, Dowd SE,. Chronic wounds and the medical biofilm paradigm. J Wound Care 2010; 19: 45-46, 48-50, 52-3.
9. Merckoll P, Jonassen TÃ, Vad ME, Jeansson SL, Melby KK,. Bacteria, biofilm and honey: a study of the effects of honey on "planktonic" and biofilm-embedded chronic wound bacteria. Scand J Infect Dis 2009; 41: 341-347.
10. Mycocock G,. Methicillin/antiseptic-resistance Staphylococcus aureus. Lancet 1985; ii: 949-950.
11. Reverdy ME, Bes M, Brun Y, Fleurette J,. Evolution de la resistance aux antibiotiques et aux antiseptiques de souche hospitalieres de Staphylococcus aureus isolees de 1980 a 1991. Pathol Biol 1993; 41: 897-904. (Pubitemid 23355025)
12. Reverdy ME, Bes M, Nervi C, Marta A, Fleurette J,. Activity of four antiseptics (acriflavine, benzalkonium chloride, chlorhexidine digluconate and hexamidine di-isethionate) and of ethidium bromide on 392 strains representing 26 Staphylococcus species. Med Microbiol Lett 1992; 1: 56-63.
13. Behr H, Reverdy ME, Mabilat C, Freney J, Fleurette J,. Relation entre le niveau des concentrations minimales inhibitrices de cinq antiseptiques etal presence du gene qacA chez Staphylococcus aureus. Pathol Biol 1994; 42: 438-444. (Pubitemid 24240375)
14. Russell AD,. Plasmids and bacterial resistance to biocides. J Appl Microbiol 1997; 82: 155-165. (Pubitemid 27329760)
15. Sasatsu M, Shibata Y, Noguchi N, Kono M,. High-level resistance to ethidium bromide and antiseptics in Staphylococcus aureus. FEMS Microbiol Lett 1992; 93: 109-114.
16. Sasatsu M, Shimuzu K, Noguchi N, Kono M,. Triclosan-resistant Staphylococcus aureus. Lancet 1993; 341: 756.
17. Irizarry L, Merlin T, Rupp J, Griffith J,. Reduced susceptibility of methicillin-resistant Staphylococcus aureus to cetylpyridinium chloride and chlorhexidine. Chemotherapy 1996; 42: 248-252. (Pubitemid 26174128)
18. McDonnell G, Russell AD,. Antiseptics and disinfectants: activity, action and resistance. Clin Microbiol Rev 1999; 12: 147-179. (Pubitemid 29055958)
19. Russell AD,. Biocide use and antibiotic resistance: the clinical relevance of laboratory findings to clinical and environmental situations. Lancet 2003; 3: 794-803. (Pubitemid 37489963)
20. Lamp KC, Rybak MJ, Bailey EM, Kaatz GW,. In vitro pharmacodynamic effects of concentration, pH and growth phase on serum bactericidal activities of daptomycin and vancomycin. Antimicrob Agents Chemother 1992; 36: 2709-2714.
21. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. Approved standard, 8th ed. NCCLS Document M2-a8. Wayne, PA: NCCLS, 2003.
22. Clutterbuck AL, Cochrane CA, Dolman J, Percival SL,. Evaluating antibiotics for use in medicine using a poloxamer biofilm model. Ann Clin Microbiol Antimicrob 2007; 6: 2.
23. Castellano JJ, Shafii SM, Ko F, Donate G, Wright TE, Mannari RJ, Payne WG, Smith DJ, Robson MC,. Comparative evaluation of silver-containing antimicrobial dressings and drugs. Int Wound J 2007; 4: 114-122.
24. Cavanagh MH, Burrell RE, Nadworny PL,. Evaluating antimicrobial efficacy of new commercially available silver dressings. Int Wound J 2010; 7: 394-405.
25. Hill KE, Malic S, McKee R, Rennison T, Harding KG, Williams DW, Thomas DW,. An in vitro model of chronic wound biofilms to test wound dressings and assess antimicrobial susceptibilities. J Antimicrob Chemother 2010; 65: 1195-1206.
26. Barcia-Macay M, Seral C, Mingeot-Leclercq MP, Tulkens PM, Van, Bambeke F,. Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages. Antimicrobial Agents Chemother 2006; 50: 841-851. (Pubitemid 43327786)
27. Emrich N, Helsig A, Stubbings W, Labischinkski Heisig P,. Antibacterial activity of finafloxacin under different pH conditions against isogenic strains of Escherichia coli expressing combinations of defined mechanism of fluoroquinolone resistance. J Antimicrob Chemother 2010; 65: 2530-2533.
28. Eisenberg ES, Mandel LJ, Kaback HR, Miller MH,. Quantitative association between electrical potential across the cytoplasmic membrane and early gentamicin uptake and killing in Staphylococcus aureus. J Bacteriol 1984; 157: 863-867. (Pubitemid 14154448)
29. Thomas JG, Slone W, Linton S, Okel T, Corum L, Percival SL,. In vitro antimicrobial efficacy of a silver alginate dressing on burn wound isolates. J Wound Care 2011; 20: 124-128.
30. Percival SL, Bowler PG, Russell D,. Bacterial resistance to silver in wound care. J Hosp Infect 2005; 60: 1-7. (Pubitemid 40485843)
31. Kolawole DO,. Resistance mechanisms of mucoid-grown Staphylococcus aureus to the antibacterial action of some disinfectants and antiseptics. FEMS Microbiol Lett 1984; 25: 205-209. (Pubitemid 15181058)
32. Baddour MM,. A study of the effects of different disinfectants used in Riyadh hospitals and their efficacy against methicillin resistant Staphylococcus aureus (MRSA). Saudi Pharm J 2008; 16: 165-170.
33. Lambert RJ,. Comparative analysis of antibiotic and antimicrobial biocide susceptibility data in clinical isolates of methicillin-sensitive Staphylococcus aureus, methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa between 1989 and 2000. J Appl Microbiol 2004; 97: 699-711. (Pubitemid 39331576)
34. Lyon BR, May JW, Skurray RA,. Tn 4001: a gentamicin and kanamycin resistance transposon in Staphylococcus aureus. Mol Gen Genet 1984; 193: 554-556. (Pubitemid 14162185)
35. Suller MT, Russell AD,. Antibiotic and biocide resistance in methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus. J Hosp Infect 1999; 43: 281-291. (Pubitemid 30045827)
36. Percival SL, Hill KE, Malic S, Thomas DW, Williams DW,. Antimicrobial tolerance and the significance of persister cells in recalcitrant chronic wound biofilms. Wound Rep Regen 2011; 19: 1-9.
37. Percival SL, Bowler P, Woods EJ,. Assessing the effect of an antimicrobial wound dressing on biofilms. Wound Rep Regen 2008; 16: 52-57.
38. Thorn RM, Greenman J,. A novel in vitro flat-bed perfusion biofilm model for determining the potential antimicrobial efficacy of topical wound treatments. J Appl Microbiol 2009; 107: 2070-2079.
39. Wirtanen G, Salo S, Allison DG, Mattila-Sandholm T, Gilbert P,. Performance evaluation of disinfectant formulations using poloxamer-hydrogel biofilm-constructs. J Appl Microbiol 1998; 85: 965-971. (Pubitemid 28559727)
40. Sincock SA, Rajwa B, Robinson PJ,. Characteristics and dynamics of bacterial populations with poloxamer hydrogel biofilm constructs. Abstract International Society for Analytical Cytology XX International Congress, May 20-25, 2000, Le Corum, Montpellier, France 6451.